Reuters logo
BRIEF-aap Implantate sees FY sales and EBITDA at lower end of guidance​​
November 14, 2017 / 7:55 AM / 6 days ago

BRIEF-aap Implantate sees FY sales and EBITDA at lower end of guidance​​

Nov 14 (Reuters) - AAP IMPLANTATE AG:

* ‍EBITDA IMPROVED IN Q3 OF 2017 BY 11% YEAR-ON-YEAR TO EUR -1.6 MILLION (Q3/2016: EUR -1.8 MILLION)​

* Q3 ‍SALES OF EUR 2.6 MILLION (Q3/2016: EUR 2.9 MILLION)​

* ‍AAP EXPECTS SALES AND EBITDA TO BE AT LOWER END OF GUIDANCE FOR FINANCIAL YEAR 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below